These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28860488)

  • 61. Degradation of specific glycosaminoglycans improves transfection efficiency and vector production in transient lentiviral vector manufacturing processes.
    Williams-Fegredo T; Davies L; Knevelman C; Mitrophanous K; Miskin J; Rafiq QA
    Front Bioeng Biotechnol; 2024; 12():1409203. PubMed ID: 38994127
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor.
    Valkama AJ; Leinonen HM; Lipponen EM; Turkki V; Malinen J; Heikura T; Ylä-Herttuala S; Lesch HP
    Gene Ther; 2018 Jan; 25(1):39-46. PubMed ID: 29345252
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimized PEI-based Transfection Method for Transient Transfection and Lentiviral Production.
    Yang S; Zhou X; Li R; Fu X; Sun P
    Curr Protoc Chem Biol; 2017 Sep; 9(3):147-157. PubMed ID: 28910855
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing.
    Banos-Mateos S; Lopez-Robles C; Yubero ME; Jurado A; Arbelaiz-Sarasola A; Lamsfus-Calle A; Arrasate A; Albo C; Ramírez JC; Fertin MJ
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205190
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor.
    Fiol CR; Collignon ML; Welsh J; Rafiq QA
    Mol Ther Methods Clin Dev; 2023 Sep; 30():221-234. PubMed ID: 37528866
    [TBL] [Abstract][Full Text] [Related]  

  • 67. End-to-End Approach to Surfactant Selection, Risk Mitigation, and Control Strategies for Protein-Based Therapeutics.
    Morales AM; Sreedhara A; Buecheler J; Brosig S; Chou D; Christian T; Das T; de Jong I; Fast J; Jagannathan B; Moussa EM; Nejadnik MR; Prajapati I; Radwick A; Rahman Y; Singh S
    AAPS J; 2022 Dec; 25(1):6. PubMed ID: 36471030
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lentiviral Vector Bioprocessing.
    Perry C; Rayat ACME
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Viral vector platforms within the gene therapy landscape.
    Bulcha JT; Wang Y; Ma H; Tai PWL; Gao G
    Signal Transduct Target Ther; 2021 Feb; 6(1):53. PubMed ID: 33558455
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Innovative Alternatives for Continuous
    Álvarez Martínez JA; Figueroa Millán JV; Ueti MW; Rojas-Martínez C
    Pathogens; 2020 May; 9(5):. PubMed ID: 32370024
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of a laboratory scalable process for enhancing lentivirus production by transient transfection of HEK293 adherent cultures.
    Ho YK; Too HP
    Gene Ther; 2019 Nov; 27(10-11):482-494. PubMed ID: 32341483
    [TBL] [Abstract][Full Text] [Related]  

  • 72. LentiPro26: novel stable cell lines for constitutive lentiviral vector production.
    Tomás HA; Rodrigues AF; Carrondo MJT; Coroadinha AS
    Sci Rep; 2018 Mar; 8(1):5271. PubMed ID: 29588490
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD
    Lv Q; Wang K; Qiao S; Yang L; Xin Y; Dai Y; Wei Z
    Cell Death Dis; 2018 Feb; 9(3):258. PubMed ID: 29449535
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus.
    Kobayashi M; Iida A; Ueda Y; Hasegawa M
    J Virol; 2003 Feb; 77(4):2607-14. PubMed ID: 12551999
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3.
    Jung C; Grzybowski BN; Tong S; Cheng L; Compans RW; Le Doux JM
    Biotechnol Prog; 2004; 20(6):1810-6. PubMed ID: 15575716
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins.
    Paul-Smith MC; Pytel KM; Gelinas JF; McIntosh J; Pringle I; Davies L; Chan M; Meng C; Bell R; Cammack L; Moran C; Cameron L; Inoue M; Tsugumine S; Hironaka T; Gill DR; Hyde SC; Nathwani A; Alton EWFW; Griesenbach U
    Gene Ther; 2018 Aug; 25(5):345-358. PubMed ID: 30022127
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Cloning and expression of the six coding genes of sendai virus BB1 strain].
    Zhang HF; Yang Y; Dong XY; Wu XB
    Bing Du Xue Bao; 2009 May; 25(3):213-9. PubMed ID: 19634765
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Assessment of selected media supplements to improve F/HN lentiviral vector production yields.
    Gélinas JF; Davies LA; Gill DR; Hyde SC
    Sci Rep; 2017 Aug; 7(1):10198. PubMed ID: 28860488
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.